Drug Report History #279200
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v5-EN | Version v2-FR |
|---|---|---|
| Language | English (Updated) | French |
| Date Updated | 2026-03-17 (Updated) | 2026-03-02 |
| Drug Identification Number | 02519828 | 02519828 |
| Brand name | JAMP ALENDRONATE / VITAMIN D3 | JAMP ALENDRONATE / VITAMIN D3 |
| Common or Proper name | Alendronic Acid and Cholecalciferol Tablets | Alendronic Acid and Cholecalciferol Tablets |
| Company Name | JAMP PHARMA CORPORATION | JAMP PHARMA CORPORATION |
| Ingredients | ALENDRONIC ACID VITAMIN D3 | ALENDRONIC ACID VITAMIN D3 |
| Strength(s) | 70MG 2800UNIT | 70MG 2800UNIT |
| Dosage form(s) | TABLET | TABLET |
| Route of administration | ORAL | ORAL |
| Packaging size | 4 | 4 |
| Anatomical Therapeutical Chemical (ATC) code | M05BB | M05BB |
| Anatomical Therapeutical Chemical (ATC) description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2026-02-26 | 2026-02-26 |
| Estimated end date | 2026-03-06 | 2026-03-06 |
| Actual end date | 2026-03-04 (Updated) | |
| Shortage status | Resolved (Updated) | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |